DEVELOPMENT AND VALIDATION OF ULTRAVIOLET-SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF FEBUXOSTAT FOR CONDUCTING IN-VITRO QUALITY CONTROL TESTS IN BULK AND PHARMACEUTICAL DOSAGE FORMS
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i9.25550Keywords:
Ultraviolet-spectrophotometric, Febuxostat, ValidationAbstract
Objective: A simple, accurate, and selective ultraviolet-spectrophotometric method has been developed for the estimation of febuxostat in the bulk and pharmaceutical dosage forms.
Method: The method was developed and validated according to International Conference on Harmonization (ICH Q2 R1) guidelines. The developed method was validated statistically with respect to linearity, range, precision, accuracy, ruggedness, limit of detection (LOD), limit of quantitation (LOQ), and recovery. Specificity of the method was demonstrated by applying different stressed conditions to drug samples such as acid hydrolysis, alkaline hydrolysis, oxidative, photolytic, and thermal degradation.
Results: The study was conducted using phosphate buffer pH 6.8 and λmax was found to be 312 nm. Standard plot having a concentration range of 1–10 μg/ml showed a good linear relationship with R2=0.999. The LOD and LOQ were found to be 0.118 μg/ml and 0.595 μg/ml, respectively. Recovery and percentage relative standard deviations were found to be 100.157±0.332% and <2%, respectively.
Conclusion: Proposed method was successfully applicable to the pharmaceutical formulations containing febuxostat. Thus, the developed method is found to be simple, sensitive, accurate, precise, reproducible, and economical for the determination of febuxostat in pharmaceutical dosage forms.
Downloads
References
Panda BK, Parge V, Singh P, Patel CS, Marne SR. Febuxostat, a non-purine selective xanthine oxidase inhibitor in the management of hyperuricemia and chronic gout: A systematic review. J Adv Sci Res 2012;3:3-11.
Shinde SS, Deshmukh AS, Nagadkar PP, Tiwari KJ. Study of febuxostat for the management of hyperuricemia in gout. Int J Pharm Pharm Res 2015;4:279-88.
Pandey A, Chaturvedi M, Prakash H, Meena D. Febuxostat–a new treatment for hyperuricaemia in gout–a review article. Natl J Physiol Pharm Pharmacol 2012;2:23-8.
Bisht M, Bist SS. Febuxostat: A novel agent for management of hyperuricemia in gout. Indian J Pharm Sci 2011;73:597-600.
Raviteja, Naik NS, Gayathri, Zahera F. Development and validation of UV spectrophotometric method of febuxostat in bulk and tablet formulations. Int J Chem Pharm Sci 2013;1:337-41.
Spandana R, Latha PE, Susmitha J. Method development and validation of spectrophotometric method for the estimation of febuxostat in pure and tablet dosage form. Int J Pharm Pharm Res 2015;3:38-46.
Sudhir MS, Mohan PM, Nadh RV. Simple and validated ultraviolet spectrophotometric method for the estimation of febuxostat in bulk and pharmaceutical dosage forms. Orient J Chem 2013;29:235-40.
Sowjanya G, Srinivas L, Rajasri A. New validated UV spectrophotometric methods for the determination of febuxostat in bulk and formulation. Cibtech J Pharm Sci 2014;3:7-13.
Bagga P, Salman M, Siddiqui HH, Ansari AM, Mehmood T, Singh K. A simple UV spectrophotometric method for the determination of Febuxostat in bulk and pharmaceutical formulations. Int J Pharm Sci Res 2011;2:2655-9.
Sheth M, Joshi S, Patel M. Development and application of difference spectrophotometric method for the determination of febuxostat in tablets. Int J Pharm Sci Res 2012;3:1621-4.
Musirike MR, Reddy HK, Mallu UR. Development and validation of reverse phase-ultra performance liquid chromatographic method for estimation of related substances in Febuxostat drug substance. Pharm Anal Acta 2015;6:1-10.
Ding X, Zhang Q, Wang Z, Lin G. Development and validation of liquid chromatography-mass spectrometry method for determination of febuxostat in rat plasma and its application. Lat Am J Pharm 2012;31:321-5.
Prasad AR, Ratna JV. Development and validation of a simple UV-spectrophotometric method for the determination of ciprofloxacin HCl present in taste masked drug resin complex. Int J App Pharm 2018;10 Suppl 3:37-41.
Zadbuke N, Shahi S, Jadhav A, Borde S. Development and validation of UV-Visible Spectroscopic method for estimation of carbamazepine in bulk and tablet dosage. Int J Pharm Pharm Sci 2015;8 Suppl 2:234-8.
Wamorkar V, Manjunath SY, Varma MM. Development and validation of UV spectroscopic method for determination of metoclopramide hydrochloride in bulk and tablet formulation. Int J Pharm Pharm Sci 2011;3 Suppl 3:171-4.
Ethiraj R, Thiruvengadam E, Sampath VS, Vahid A, Raj J. Development and validation of stability indicating spectroscopic method for content analysis of ceftriaxone sodium in pharmaceuticals Int Sch Res Notices 2014. DOI: 10.1155/2014/278173.
Monica SA, Gautami J. Design and evaluation of topical hydrogel formulation of diclofenac sodium for improved therapy. Int J Pharm Sci Res 2014;5 Suppl 5:1973-80.
Yadav N, Goyal A. A validated Spectrophotometric method for determination of vilazodone hydrochloride in pharmaceutical dosage form. Int J Curr Pharm Res 2016;9 Suppl 1:132-5.
Syed MR, Hashmi S, Naik JB. UV Spectrophotometric method development and validation for determination of paroxetine hydrochloride in pharmaceutical dosage form. Int J Pharm Pharm Sci 2010;2 Suppl 2:43-5.
Swetha CH, Velmurugun S, Raju PN, Reddy GN. Formulation and evaluation of clarithromycin topical gel. Int J Drug Dev Res 2013;5:194-202.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
